NAPSRx /
CNPR
/ /
exam
/ /
(Revised
/ /
18th
/ /
Edition)
/ /
Questions With Correct Answers
/ // // //
what /
/does //
a/
/STAT /
/order //mean? //- //correct //answer(s) //✔✔ //a //drug //needed //immediately //and //given //only //once
what /
/information /
/does /
/the /
/overdosage /
/section /
/of /
/the /
/labeling /
/provide? //- //correct //answer(s) //✔✔ //signs, //symptoms //and //treatment //of //acute //overdoses
types //of //drug-
drug /
, /interactions: //- /
/correct //answer(s) //✔✔ //duplication, //opposition //(antagonism) //and //alteration //(p.51)
tolerance /
/vs /
/resistance //- /
/correct /
/answer(s) /
/✔✔ /
/tolerance /
/is /
/the //diminished //response //to //a //drug; //resistance //is //the //cells //ability //to //resist //the //effects //of
//the //drug //on //them.
abbreviated /
/new /
/drug /
/application /
/(ANDA) //- /
/correct /
/answer(s) /
/✔✔ /
/the /
/process /
/by /
/which /
/applicants /
/must /
/scientifically /
/demonstrate /
/to //the //FDA //that //their //generic //product //is //bioequivalent //to //or //performs //in //the //same //way
//as //the //innovator //drug, //no //duplicate //testing //(p. //75)
the //Hatch-Waxman //Act //of //1984 //- //correct //answer(s) //✔✔ //-
A.K.A. //Drug //Price //Competition //and //Patent //Restoration //Act
CNPR
/ /
exam
/ /
(Revised
/ /
18th
/ /
Edition)
/ /
Questions With Correct Answers
/ // // //
what /
/does //
a/
/STAT /
/order //mean? //- //correct //answer(s) //✔✔ //a //drug //needed //immediately //and //given //only //once
what /
/information /
/does /
/the /
/overdosage /
/section /
/of /
/the /
/labeling /
/provide? //- //correct //answer(s) //✔✔ //signs, //symptoms //and //treatment //of //acute //overdoses
types //of //drug-
drug /
, /interactions: //- /
/correct //answer(s) //✔✔ //duplication, //opposition //(antagonism) //and //alteration //(p.51)
tolerance /
/vs /
/resistance //- /
/correct /
/answer(s) /
/✔✔ /
/tolerance /
/is /
/the //diminished //response //to //a //drug; //resistance //is //the //cells //ability //to //resist //the //effects //of
//the //drug //on //them.
abbreviated /
/new /
/drug /
/application /
/(ANDA) //- /
/correct /
/answer(s) /
/✔✔ /
/the /
/process /
/by /
/which /
/applicants /
/must /
/scientifically /
/demonstrate /
/to //the //FDA //that //their //generic //product //is //bioequivalent //to //or //performs //in //the //same //way
//as //the //innovator //drug, //no //duplicate //testing //(p. //75)
the //Hatch-Waxman //Act //of //1984 //- //correct //answer(s) //✔✔ //-
A.K.A. //Drug //Price //Competition //and //Patent //Restoration //Act
